- Aurora Cannabis (TSX:ACB) completed a settlement resolving the ongoing patent litigation with Willow Biosciences Inc. (TSX: WLLW)
- The Edmonton-based cannabis company commenced a patent infringement action in July 2021, alleging that Willow’s biosynthetic process for synthesizing cannabinoids infringed Aurora’s exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC)
- In December 2022, Willow announced it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California
- Shares of Aurora Cannabis last traded at $0.58, and Willow last traded at $0.09 per share
Aurora Cannabis (TSX:ACB) completed a settlement resolving the ongoing patent litigation with Willow Biosciences Inc. (TSX: WLLW).
The Edmonton-based cannabis company commenced a patent infringement action in July 2021, alleging that Willow’s biosynthetic process for synthesizing cannabinoids infringed Aurora’s exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC).
The technology of the asserted patents was invented by Jonathan Page who was an Anandia co-founder and former chief science officer at Aurora, and his colleagues, after their work at the University of Saskatchewan and the NRC in identifying key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.
In December 2022, Willow announced it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California.
“We are pleased with the negotiated settlement, which provides Aurora a favourable resolution that ensures our Canadian cannabis related patent rights are respected,” Miguel Martin, chief executive officer of Aurora said in a news release. “Aurora is a pioneer in terms of the company’s genetics work in the Canadian cannabis industry and will not hesitate to continue to take the steps necessary, including legal action, to protect and enforce our intellectual property rights when necessary.”
Aurora Cannabis has a wide range of adult-use brands under its portfolio, including Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and Greybeard.
Willow Biosciences develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets.
Shares of Aurora Cannabis last traded at $0.58, and Willow last traded at $0.09 per share.
Join the discussion: Find out what everybody’s saying about public companies and hot topics about stocks at Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.